knowledge -WSS

knowledge

author：Wikipedia 2025-09-27 10:03:14 - browse：89

Bob Kocher, a partner at venture capital firm Venrock, speaking at STAT's Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — Health tech investor Bob Kocher has seen some bad AI-related startup pitches in his time. The worst typically involve AI chatbots masquerading as romantic partners to improve people’s mental health.

“They pitch it to me as a mental health improvement model,” Kocher, a partner at venture capital firm Venrock, said. “If you’re sad, anxious, or depressed, why bother with people?”

Kocher, who is also a doctor and helped write the Affordable Care Act as an Obama administration health official, shared his thoughts on the biggest questions facing digital health at STAT’s Breakthrough Summit on Thursday. Besides sharing a peek inside his generative AI pitch-filled inbox, Kocher talked about cybersecurity vulnerabilities in health systems and venture capitalists buying hospitals.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Male and female sex labels in research insufficient, scientists say

WSS

Scientists boost immune system in aging mice by making it youthful

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

FDA advisers back CAR

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Boston's new lab space is opening empty

John Green on his newest strategy for fighting tuberculosis

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Dobbs anniversary: the lost opportunity of abortion as health care

Abortion pill case raises question: who can sue the FDA?

Wildfire smoke exposes gaps in outdoor worker protections

How many hemophilia patients actually want gene therapy?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

John Green on his newest strategy for fighting tuberculosis

Anesthesiologist group: stop taking Ozempic before surgery

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Scientists boost immune system in aging mice by making it youthful

entertainment

Readout Newsletter: Merck, Vertex, and Viking updates

Steward Health Care Massachusetts hospitals face fiscal disaster

President Biden's budget: Here's what you might have missed

EPA limits use of carcinogenic gas for sterilizing medical devices

President Biden's budget: Here's what you might have missed

Male and female sex labels in research insufficient, scientists say

knowledge

focus

focus

focus